Advertisement

Topics

Marina Biotech, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175

11:09 EDT 12 Oct 2018 | BioPortfolio Reports

Marina Biotech, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Marina Biotech, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Marina Biotech, Inc. Marina Biotech or the company' is a biotechnology company focused on the development and commercialization of nucleic acidbased therapies to treat orphan diseases. The company provides drugs to treat hypertension, arthritis, pain and others. The company offers Prestalia, a singlepill fixed dose combination and amlodipine besylate, a calcium channel blocker for the treatment of hypertension. Its clinical development programs include IT102 and IT103, a celecoxib program drug for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against betacatenin, combined with IT102 to for familial adenomatous polyposis; and CEQ508 combined with IT103 to treat colorectal cancer. The company is into research and development of pipeline products. Marina Biotech is headquartered in City of Industry, California, the US.


Scope


Detailed information on Marina Biotech, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Marina Biotech, Inc. in the form of a SWOT analysis

An indepth view of the business model of Marina Biotech, Inc. including a breakdown and examination of key business segments

Intelligence on Marina Biotech, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Marina Biotech, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Marina Biotech, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Marina Biotech, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Marina Biotech, Inc.'s business structure, strategy and prospects.

Original Article: Marina Biotech, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Marina Biotech, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...